Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Matrixx net sales down

This article was originally published in The Tan Sheet

Executive Summary

Sales of Zicam cough/cold products increased about 15% in Matrixx Initiatives' second quarter, the firm reports Oct. 24. Marketing spending for the 2007/2008 cold season will increase 15%, the company projects. However, net sales in the July-September period for the Phoenix-based OTC healthcare firm fell 16% to $28.6 mil. and net income declined 10.4% to $6.4 mil. In a same-day earnings call, Matrixx executives said the firm's performance is in line with expectations due to large retail customers' caution in off-season purchases of cough/cold products...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS101050

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel